MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
52.17
+0.29 (0.56%)
Dec 20, 2024, 4:00 PM EST - Market closed

MLTX Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for MLTX stock have an average target of 78.33, with a low estimate of 62 and a high estimate of 104. The average target predicts an increase of 50.14% from the current stock price of 52.17.

Analyst Consensus: Buy
Target Low Average Median High
Price $62 $78.33 $73 $104
Change +18.84% +50.14% +39.93% +99.35%
* Price targets were last updated on Nov 14, 2024.

Analyst Ratings

The average analyst rating for MLTX stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24
Strong Buy 555553
Buy 322233
Hold 232222
Sell 000000
Strong Sell 000000
Total 101099108

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$100
Strong Buy Reiterates $100 +91.68% Nov 14, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$100
Strong Buy Reiterates $100 +91.68% Nov 8, 2024
Wedbush
Wedbush
Buy
Initiates
$92$73
Buy Initiates $92$73 +39.93% Nov 5, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$100
Strong Buy Reiterates $100 +91.68% Oct 15, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
n/a
Buy Reiterates n/a n/a Sep 23, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.81
from -0.73
EPS Next Year
-2.73
from -1.81
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028
Revenue
------127.10M570.11M
Revenue Growth
-------348.55%
EPS
-8.21-1.70-0.73-1.81-2.73-3.32-3.50-0.12
EPS Growth
--------
Forward PE
--------
No. Analysts ---18171355
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 202420252026202720282029
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202420252026202720282029
High -1.69 -2.34 -2.27
Avg -1.81 -2.73 -3.32
Low -1.89 -3.16 -4.37

EPS Growth

EPS Growth 202420252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.